probably inactive, the assay level rose from 120 to 160 ,ug in three minutes after the injection, but fluctuated between these levels over the day. This doubtful rise cannot be compared to that seen in the other subjects. There being no obvious technical reason for these findings it is possible that there is some alteration in handling of GH or at least of exogenous GH in acromegaly.
From these results it appears that we are unable to assess activity in cases of acromegaly or gigantism by the assay of GH levels in the serum. More cases of acromegaly of well-defined activity must be studied before one can say whether the handling of a load of GH may distinguish the active cases. At present the assay is most reliable in distinguishing cases of hypopituitarism.
Immunoassay of Growth Hormone in Human Serum by R M Ehrlich MD & P J Randle PhD MB (Cambridge)
An immunological assay for growth hormone in human serum employing hemagglutination inhibition has recently been described by . The method of assay depends upon the fact that erythrocytes coated with human growth hormone (HGH) prepared by the method of Raben (1959) are agglutinated by rabbit anti-HGH serum and that prior addition of a definite quantity of HGH to the antiserum will inhibit such agglutination. When a constant amount of antiserum and serial dilutions of HGH or human serum is employed, the HGH content of the serum may readily be calculated.
Experimental procedure: Sheep erythrocytes were treated with tannic acid as described by and then suspended in a solution containing 10 ,ug/ml of HGH prepared by the method of Raben (1959) from human pituitary glands obtained at autopsy. For assay of HGH, 0 1 ml of a 1 % suspension of HGH-coated erythrocytes, 0-1 ml of serial dilutions of human serum (1: 2 to I : 80) or of HGH (0 075 to 0 005 pg/ml) and 0ml of an appropriate dilution of antiserum were mixed in small round-bottomed tubes of as uniform a shape as possible and run in duplicate. The diluent in each case was normal rabbit serum (1: 150 in 0-15M phosphate buffer pH 7 2). The tubes were allowed to stand at room temperature for four to twelve hours and the presence or absence of agglutination defined by the pattern of settling (Stavitsky 1954) . Since the titre of antiserum was found to vary by a small but significant amount each day it was particularly important to measure the titre of the antiserum immediately before each assay. The final dilution of antiserum employed was approximately the titre.
Results: The concentration of HGH in random samples of serum from normal adults was found to be 19*5+07 ,ug/100 ml (mean±S.E.M.): the range of concentrations was from 9 to 30 pig/100 ml in 24 subjects (ages 20 to 40 years). Several of the samples were reassayed many times and the values obtained on different days were essentially similar. When different amounts of HGH were added to normal human serum approximately 80-100 % of the added HGH was recovered in the assay. After fasting overnight the values were not significantly different from those recorded above, though experiments to date have not excluded the possibility that the serum HGH concentration may be lower in the post-absorptive state than after fasting. The mean serum HGH concentration in ten hypophysectomized patients was reduced to 12 2±3-3 (range<2 to 29). In serum from seven acromegalics the HGH concentration was frequently increased (mean 30 8±2; range 22 to 56 ,ug/100 ml).
In normal pregnancy the serum concentration of HGH was found to be within the normal range. In successive trimesters the concentrations were 22 5+2 8 (8 subjects) 20 7± 1 2 (15 subjects) and 19 2+1 7 (13 subjects). On the other hand, in 10 patients studied two to ten days post partum the mean HGH concentration was found to be increased (mean 36±4-4; range 21-66).
Comment: These results confirm the conclusion of that an immunological assay for HGH based on hmmagglutination inhibition can be successfully applied to the estimation of HGH in serum. The values which have been obtained for serum of normal adults are very similar to those of Read but lower than those reported by McGarry et al. (1960) . Our findings also confirm that the serum concentration of HGH may be increased in some cases of acromegaly and reduced in hypophysectomized patients. The finding of values within the normal range for serum HGH concentration in 6 of 10 patients hypophysectomized by surgery or irradiation could be explained if these patients had sufficient residual pituitary tissue to maintain near normal serum HGH concentrations. Recent work of Campbell (1959) has emphasized the functional significance of minute amounts of pituitary tissue remaining after hypophysectomy.
Serum HGH concentrations in pregnancy and in the post-partum period have not previously been recorded. Our findings indicate that the concentration is normal during pregnancy but increased in the post-partum period. This is of special interest because of the known requirement for growth hormone in mammary gland development and in milk secretion (Lyons et al. 1955 ) but more particularly because it is known that the administration of growth hormone to animals in declining lactation leads to a resurgence of milk production (Cotes et al. 1949 ).
The Immunological Assay of Growth Hormone [Abstract]
by M Hartog BM MRCP and Russell Fraser MD FRCP (London)
The paper described the technique, its accuracy and the results obtained in 18 normal subjects, 11 patients with acromegaly and 7 hypophysectomized patients. This work has recently been published (J. Endocrin. 22, 101) .
In addition results in 5 patients with active acromegaly who had been treated by pituitary implantation were presented. Two of these patients experienced no improvement following implantation of 198Au and their serum GH values were unchanged. Another patient whose serum GH was also unchanged experienced some improvement following 198Au. Two patients had clear clinical improvement, one following 198Au and the other following 90Y implantation, and their serum GH values fell significantly from their pre-implant figures.
Immunological Study of Human Gonadotrophins by W R Butt PhD ARIC, A C Crooke MD MRCP and F J Cunningham BSC (Birmingham)
There is an extensive literature on the early work on antibodies or antihormones to gonadotrophins which has been fully reviewed by Zondek & Sulman (1942) and by Evans & Simpson (1950) . Interest in the subject has been renewed by the preparation of -purer hormones and by more recent developments in immunological techniques (Henry & van Dyke 1958) . Recently Wide & Gemzell (1960 ) and Brody & Carlstr6m (1960 , 1961 have claimed to have developed immunological assays for chorionic gonadotrophin as a test for pregnancy. We have been interested in cross-reactions between different gonadotrophic antigens and antisera which suggest that they may be unspecific (Butt et al. 1960) .
Antisera have been raised against gonadotrophins from the urine of both postmenopausal (HMG, human menopausal gonadotrophin) and pregnant women (HCG, human chorionic gonadotrophin) and also from human pituitary glands (HPG). The extracts from the urine of postmenopausal women have been purified using ion exchange materials by methods described previously (Butt et al. 1959) The antigens were dissolved in saline and mixed with an equal weight of bentonite to which they adsorb strongly. 2-0 ml of the suspension, usually containing 0 5 mg protein were given intravenously to rabbits twice a week for three or more weeks. Biologically active antisera have been obtained against HMG, HPG and HCG using the following amounts of protein:
(1) HMG 20 mg of the DEAE fraction having a total potency equivalent to 300 mg of the International Reference substance, HMG24.
(2) HPG 5 mg of the DEAE fraction having a total potency equivalent to 1,300 mg HMG24
(3) HCG 2*75 mg having a total potency equivalent to 4,400 i.u. The activity of the antisera was tested in vivo using mice or rats. Each serum was injected intraperitoneally and the next day the antigen was given subcutaneously. Antisera to both HMG and
